Food Safety Testing Market Size Worth Around US$ 25 billion by 2026: Acumen Research and Consulting
/
Date06 Mar 2019
Email Print Friendly Share LOS ANGELES, March 06, 2019 (GLOBE NEWSWIRE) — The global food safety testing market is expected to grow at significant CAGR around... Read More →
TWC Enterprises Limited Announces 2018 Year End Results and Eligible Cash Dividend
/
Date06 Mar 2019
Email Print Friendly Share KING CITY, Ontario, March 06, 2019 (GLOBE NEWSWIRE) — TWC Enterprises Limited (TSX: TWC) Consolidated Financial Highlights (unaudited) (in thousands... Read More →
Shawcor Declares Quarterly Dividend
/
Date06 Mar 2019
Email Print Friendly Share TORONTO, March 06, 2019 (GLOBE NEWSWIRE) — The Shawcor Ltd. (TSX: SCL) Board of Directors today declared a dividend of fifteen... Read More →
Shawcor Ltd. Announces Fourth Quarter 2018 Results
/
Date06 Mar 2019
Email Print Friendly Share Fourth quarter 2018 revenue was $354 million, an increase of 1% from the $351 million reported in the third quarter of... Read More →
The Ensign Group Acquires Home Health and Hospice Operations in San Antonio, Texas
/
Date06 Mar 2019
Email Print Friendly Share MISSION VIEJO, Calif., March 06, 2019 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the Ensign™... Read More →
bioAffinity Technologies Selected as Finalist for Cancer Innovation Award
/
Date06 Mar 2019
Email Print Friendly Share SAN ANTONIO, March 06, 2019 (GLOBE NEWSWIRE) — Healthcare innovators Lyfebulb and Helsinn selected bioAffinity Technologies, a privately held biotech company... Read More →
Ársreikningur Fljótsdalshéraðs fyrir árið 2018
/
Date06 Mar 2019
Email Print Friendly Share Ársreikningur Fljótsdalshéraðs fyrir árið 2018. Ársreikningur Fljótsdalshéraðs fyrir árið 2018 lagður fram til fyrri umræðu í bæjarstjórn Fljótsdalshéraðs þann 6. mars... Read More →
OncoCyte Corporation to Present at Cowen and Company 39th Annual Health Care Conference in Boston
/
Date06 Mar 2019
Email Print Friendly Share ALAMEDA, Calif., March 06, 2019 (GLOBE NEWSWIRE) — OncoCyte Corporation (NYSE American: OCX), a developer of novel, non-invasive tests for the... Read More →